This clinician podcast talks about a peculiar case and predicament Dr. Kuritzky was found in. What would you do?

This clinical podcast talks about navigating the challenging workup in a patient with fatigue and low libido.

This clinical podcast talks about the common ophthalmology conditions with Dr. Nausheen Khuddus.

This clinical podcast talks about the updated guidelines for COPD according the GOLD (Global Initiative for Obstructive Lung Disease) guidelines.

This clinical podcast talks about the FDA approved and off label treatments for Diabetic Peripheral Neuropathic Pain (DPNP).

This clinician podcast talks about the updated guidelines on the 2023 standards of care in diabetes from the ADA (American Diabetes Association).

This clinician podcast talks about the 2022 NAMS position statement regarding the care and treatment for perimenopause and menopause patients.

This clinician podcast talks about the role of Expedited Partner Treatment/Therapy (EPT) for patients that test positive for Sexually Transmitted Infections (STI).

This clinician podcast talks about the use of Timolol 0.5% ophthalmic drops for the abortive therapy for migraines. 

This clinician podcast talks about the USPSTF guidelines on screening as well as supplementing vitamin D and calcium in community dwelling patients and postmenopausal women. 

This clinician podcast talks about mitigating physician - patient disparities and the steps to ensure the patient feels most comfortable.

This clinician podcast talks about the updated guidelines from the EMPEROR-Preserved trial regarding the role of SGLT2 Inhibitors in patients with Heart failure with preserved ejection fraction (HFpEF).

This clinician podcast talks about the guidelines from the ADA (American Diabetes Association) regarding the role of glucagon in diabetic patients.

This clinician podcast talks about the new updated guidelines from the USPSTF (United States Preventative Task Force) regarding low dose aspirin for primary prevention.

This clinician podcast talks about the new updated guidelines from the ADA (American Diabetes Association) regarding pharmacotherapy for Type 2 Diabetes.